EWOO.F Stock Overview
Eastwood Bio-Medical Canada Inc. markets and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
Eastwood Bio-Medical Canada Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.69 |
| 52 Week High | CA$0.69 |
| 52 Week Low | CA$0.58 |
| Beta | 0.46 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -52.81% |
| 5 Year Change | -83.23% |
| Change since IPO | 5.84% |
Recent News & Updates
Recent updates
Shareholder Returns
| EWOO.F | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | 0.09% | -0.2% |
| 1Y | n/a | 6.9% | 28.2% |
Return vs Industry: Insufficient data to determine how EWOO.F performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how EWOO.F performed against the US Market.
Price Volatility
| EWOO.F volatility | |
|---|---|
| EWOO.F Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 6.6% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in US Market | 16.0% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: EWOO.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine EWOO.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | n/a | Youngsoo Kim | www.eleotin.ca |
Eastwood Bio-Medical Canada Inc. markets and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. It distributes Eleotin that provide natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. The company’s licensed products include Eleotin A 700 for the treatment for spleen deficiency, lack of appetite, and fatigue; Eleotin AL88 for laxative; Eleotin Cal20 for bone and teeth maintenance; Eleotin V3D for development and maintenance of bones, teeth, and good health; Eleotin G2000 for cardiovascular health; Eleotin H55 for sedative and tension relief; and Eleotin Zn330 for tissue formation and metabolism.
Eastwood Bio-Medical Canada Inc. Fundamentals Summary
| EWOO.F fundamental statistics | |
|---|---|
| Market cap | US$31.22m |
| Earnings (TTM) | -US$287.81k |
| Revenue (TTM) | US$832.06k |
37.5x
P/S Ratio-108.5x
P/E RatioIs EWOO.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EWOO.F income statement (TTM) | |
|---|---|
| Revenue | CA$1.12m |
| Cost of Revenue | CA$407.21k |
| Gross Profit | CA$712.56k |
| Other Expenses | CA$1.10m |
| Earnings | -CA$387.33k |
Last Reported Earnings
Jul 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0056 |
| Gross Margin | 63.63% |
| Net Profit Margin | -34.59% |
| Debt/Equity Ratio | -9.4% |
How did EWOO.F perform over the long term?
See historical performance and comparison